Medical Equipment

Automated Drug Compounding Systems Market Insights Highlighting Growth Drivers and Opportunities Through 2030

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Automated Drug Compounding Systems Market In 2026 And What Value Is Projected For 2030?

The automated drug compounding systems market size has experienced rapid growth in recent years. It is projected to expand from $1.85 billion in 2025 to $2.08 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.3%. The market’s past growth can be attributed to the increasing adoption of automated systems in hospital pharmacies, a rising need to minimize medication errors, a growing focus on sterile and accurate drug preparation, the increasing workflow burden on pharmacy staff, and the rising demand for time-saving compounding processes.

The automated drug compounding systems market size is projected to experience swift expansion over the coming years, reaching $3.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.0%. This anticipated growth is driven by increasing investment in healthcare automation, greater integration of software and automation tools, the escalating requirement for standardization in drug compounding, a heightened focus on minimizing contamination risks, growing hospital expenditures on automation infrastructure, and the rising demand for operational efficiency within pharmacies. Key developments during this period are expected to include advancements in robotic-assisted drug compounding technologies, innovations in software integration for pharmacy management, the incorporation of AI to reduce errors in compounding processes, improvements in real-time monitoring and quality control systems, and new developments in automated sterile compounding techniques.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30527&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Automated Drug Compounding Systems Market?

The increasing prevalence of chronic diseases is anticipated to propel the growth of the automated drug compounding systems market going forward. Chronic diseases are persistent health conditions that typically advance slowly over time, such as diabetes, heart disease, and arthritis, often necessitating continuous medical attention and lifestyle management to control symptoms and prevent complications. The rise in chronic diseases is largely attributable to unhealthy lifestyles, including poor diet, physical inactivity, and smoking, which elevate the risk of conditions like diabetes, heart disease, and obesity. Automated drug compounding systems assist in chronic disease management by precisely preparing individualized medications tailored to each patient’s specific requirements. They enhance treatment accuracy and consistency, thereby reducing errors and improving long-term therapeutic outcomes. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, representing an 18% increase from 3,065,825 cases in 2022. Thus, the growing prevalence of chronic diseases is fueling the expansion of the automated drug compounding systems market. The shortage of skilled pharmacy staff is expected to drive the growth of the automated drug compounding systems market going forward. The shortage of skilled pharmacy staff refers to the limited availability of trained pharmacists and technicians capable of safely preparing and dispensing medications in hospitals, clinics, and compounding pharmacies. The increase in this shortage stems from rising patient loads and the growing incidence of chronic diseases that demand precise pharmaceutical care. Automated drug compounding systems lessen the reliance on skilled pharmacy staff by enabling accurate, consistent, and efficient preparation of medications with minimal human intervention, thereby reducing errors and the workload for pharmacy staff. For instance, in August 2024, according to the National Center for Health Workforce Studies, a US-based health workforce research organization, projections indicate a shortage of 4,980 pharmacists over the next 15 years through 2036, while overall demand for pharmacists is expected to grow 3% from 2022 to 2032, raising concerns amidst declining application trends. Therefore, the shortage of skilled pharmacy staff is propelling the growth of the automated drug compounding systems market.

What Are The Key Segments Of The Automated Drug Compounding Systems Market?

The automated drug compounding systems market covered in this report is segmented –

1) By Product: Robotic Compounding Systems, Automated Liquid Compounding Systems, Tablet And Capsule Dispensers, Injectable Compounding Robots, IV Admixture Systems, Oral Liquid Compounding Systems

2) By Component: Equipment, Software, Consumables, Services

3) By Technology: Robotic-Based Systems, Semi-Automated Systems, Gravimetric Dosing Systems, Volumetric Dosing Systems, Hybrid Dosing Systems

4) By End-User: Hospitals, Clinics, Retail Pharmacies, Compounding Pharmacies, Pharmaceutical Manufacturers

Subsegments:

1) By Robotic Compounding Systems: Fully Automated Sterile Compounding Robots, Hazardous Drug Compounding Robots, Non-Hazardous Drug Compounding Robots, High-Throughput Pharmacy Robots, Closed-System Robotic Compounding Units

2) By Automated Liquid Compounding Systems: Large-Volume Parenteral (LVP) Compounding Systems, Small-Volume Parenteral (SVP) Compounding Systems, Multi-Drug Liquid Compounding Units, Volumetric And Gravimetric Liquid Compounding Systems, Pediatric Liquid Dosing Compounding Systems

3) By Tablet and Capsule Dispensers: Automated Tablet Counting Dispensers, Unit-Dose Packaging Systems, Multi-Dose Blister Dispensing Units, Capsule Filling and Dispensing Systems, High-Speed Pharmacy Dispensing Robots

4) By Injectable Compounding Robots: Chemotherapy Drug Compounding Robots, TPN (Total Parenteral Nutrition) Compounding Robots, High-Precision Syringe Preparation Robots, Sterile Injectable Filling Robots, Hazardous Injectable Handling Systems

5) By IV Admixture Systems: Automated IV Bag Filling Systems, IV Nutrition (TPN) Admixture Systems, IV Antibiotic Admixture Devices, Pharmacy Cleanroom IV Automation Units, Closed-System IV Compounding Systems

6) By Oral Liquid Compounding Systems: Pediatric Oral Liquid Compounding Machines, Flavoring & Suspension Mixing Systems, Multi-Ingredient Oral Liquid Compounding Units, Gravimetric Oral Solution Compounding Systems, Low-Volume Oral Dosing Compounding Systems

What Key Trends Are Influencing The Development Of The Automated Drug Compounding Systems Market?

Leading entities within the automated drug compounding systems market are concentrating on creating sophisticated systems, such as total parenteral nutrition (TPN) automation systems, to enhance precision, security, and operational effectiveness in preparing customized intravenous formulations. A total parenteral nutrition (TPN) automation system represents a compounding platform designed not only to automate the blending and dispensing of total parenteral nutrition (TPN) solutions but also to incorporate prescription verification and workflow management tools, thereby minimizing human error and guaranteeing sterile, superior-quality preparation. For example, in May 2025, MediServ Co. Ltd. introduced the APEX TPN Compounding System in Riyadh, marking a new era for accuracy and automation in parenteral nutrition workflows. This system, showcased alongside its EasyComp integration software, optimizes the total parenteral nutrition (TPN) process by connecting validated prescriptions directly to sterile, precise compounding, ultimately streamlining pharmacy operations and lessening reliance on manual tasks.

Who Are The Leading Companies Operating In The Automated Drug Compounding Systems Market?

Major companies operating in the automated drug compounding systems market are Becton Dickinson and Company, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical Inc., Omnicell Inc., Eckert & Ziegler SE, Swisslog Healthcare AG, EQUASHIELD Medical Ltd., Trasis S.A., Loccioni Group S.p.A., ARxIUM Inc., Comecer S.p.A., Tema Sinergie S.p.A., Epic Medical Pte. Ltd., IBA Radiopharma Solutions S.A., Steriline S.r.l., Elysia-Raytest GmbH, Curifylabs OY, Kapsam Health Solutions Pvt. Ltd.

Read the full automated drug compounding systems market report here:

https://www.thebusinessresearchcompany.com/report/automated-drug-compounding-systems-market-report

Which Region Is Expected To Experience The Fastest Growth In The Automated Drug Compounding Systems Market?

North America was the largest region in the automated drug compounding Systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated drug compounding systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Automated Drug Compounding Systems Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30527&type=smp

Browse Through More Reports Similar to the Global Automated Drug Compounding Systems Market 2026, By The Business Research Company

Automated Compounding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

Lab Automation In Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

drug formulation global market report

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795